Responses
Regular and Young Investigator Award Abstracts
Clinical Trials Completed
545 A phase II randomized window of opportunity trial evaluating cytotoxic and immunomodulatory effects of intratumoral INT230-6 (cisplatin, vinblastine) in early stage breast cancer: the INVINCIBLE trial
Compose a Response to This Article
Other responses
No responses have been published for this article.